Aducanumab gets FDA approval, despite an FDA advisory panel saying there wasn’t enough evidence that it is effective.
FDA approves drug for use in fighting Alzheimer's disease
The FDA on Monday approved an experimental drug that aims to slow the progression of Alzheimer's disease, despite the fact that a..
WCPO Cincinnati
